Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 9 June 2009
Vol. 2, Issue 74, p. pe36
[DOI: 10.1126/scisignal.274pe36]


Insulin Signaling in Sporadic Alzheimer’s Disease

Francesca-Fang Liao1* and Huaxi Xu2*

1 Department of Pharmacology, University of Tennessee Health Science Center, 874 Union Avenue, Memphis, TN 38163, USA.
2 Neurodegenerative Disease Research Program, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.

Abstract: Excessive production of β-amyloid (Aβ) peptides from proteolytic cleavage of amyloid precursor protein is believed to play a central role in the pathogenesis of Alzheimer’s disease (AD). In particular, accumulated intracellular Aβ is found in vulnerable neurons, and the soluble oligomers of Aβ peptides [also termed Aβ-derived diffusible ligands (ADDLs)] are highly toxic to neurons. Evidence shows that both extracellular and intracellular ADDLs can compromise insulin signaling. Extracellular ADDLs can bind to synapses and decrease membrane insulin receptors (IRs) through an insulin signaling–dependent mechanism. Intracellular Aβ inhibits IR signaling in neurons by interfering with the association between phosphoinositide-dependent kinase 1 and Akt1 to preclude Akt1 activation. Together, these findings suggest that agents that stimulate insulin signaling may have neuroprotective effects. Indeed, insulin and insulin sensitizers have been shown to improve cognitive and memory functions in animal models of AD, as well as in AD patients.

* Corresponding authors. E-mail, fliao{at} (F.-F.L.); xuh{at} (H.X.)

Citation: F.-F. Liao, H. Xu, Insulin Signaling in Sporadic Alzheimer’s Disease. Sci. Signal. 2, pe36 (2009).

Read the Full Text

Attenuation of insulin signalling contributes to FSN-1-mediated regulation of synapse development.
W. L. Hung, C. Hwang, S. Gao, E. H. Liao, J. Chitturi, Y. Wang, H. Li, C. Stigloher, J.-L. Bessereau, and M. Zhen (2013)
EMBO J. 32, 1745-1760
   Abstract »    Full Text »    PDF »
Amyloid-{beta} Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway.
Y. Zhang, B. Zhou, F. Zhang, J. Wu, Y. Hu, Y. Liu, and Q. Zhai (2012)
Diabetes 61, 1434-1443
   Abstract »    Full Text »    PDF »
Metabolic Syndrome and Cognitive Decline Among the Oldest Old in Okinawa: In Search of a Mechanism. The KOCOA Project.
Y. Katsumata, H. Todoriki, Y. Higashiuesato, S. Yasura, D. C. Willcox, Y. Ohya, B. J. Willcox, and H. H. Dodge (2012)
J Gerontol A Biol Sci Med Sci 67A, 126-134
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882